万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.clinical-breast-cancer.com/
http://www.journals.elsevier.com/clinical-breast-cancer
3、投稿网址：
https://www.editorialmanager.com/cbc/default.aspx
4、官网邮箱：clbc@elsevier.com（编辑部）
5、期刊刊期：双月刊，逢双月出版。
2022年1月17日星期一
投稿须知【官网信息】
Guide for Authors
Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
Types of paper
Reviews: Review articles collate, describe, and evaluate prior publications of important clinical subjects, accompanied by critical analysis leading to rational conclusions. These Reviews should contain very little, if any, original data from an author's own study; however, such data can be used to support the overall thesis of the article. We also accept targeted mini-reviews that cover specific topics or therapies.
Mechanics: Reviews articles should contain a short abstract stating the goal of the review, an introduction, discussion, and conclusion. We recommend that Review articles contain 2000-10,000 words, ≤ 7 figures and/or tables, and 50-120 references.
Perspectives: Perspectives are more focused than reviews and seek to review a topic from a particular view or opinion. Perspectives should review a particular field to identify outstanding issues and/or challenges and propose new hypotheses or directions. A Perspective may highlight emerging science, controversial opinions, or issues within the field and seek to address these controversies. They may be accepted from a single individual or a team.
Mechanics: Perspectives should contain a short abstract stating the goal of the review, an introduction, discussion, and conclusion. We recommend that Perspective articles contain 2000-8000 words, ≤ 7 figures and/or tables, and 45-90 references.
Original Studies: Original Studies articles present results of original clinical and/or translational (basic research with clinical applications) research. This article focuses on new data collected by the author(s) during the course of a clinical or preclinical trial, although other studies may be cited for support. The Original Study should contain the following sections: Title Page, Structured Abstract, Introduction, Patients (or Materials) and Methods, Results, Discussion, and Conclusion.
Mechanics: Original Studies should contain a MicroAbstract and a structured abstract with the following sections: Background (or Purpose), Patients (or Materials) and Methods, Results, and Conclusion. Original Studies should also contain a short clinical practice points section after the conclusion of the manuscript. We recommend that Original Studies contain 2000-8000 words, ≤ 7 figures and/or tables, and 30-60 references.
Case Reports: Clinical Breast Cancer is no longer accepting Case Reports. You may consider submitting your case report to Current Problems in Cancer: Case Reports, a Journal which aims to fortify the field of oncology by publishing original case reports featuring prevention, diagnosis and treatment of cancer, supportive care, quality of life and rehabilitation.
Clinical Commentary: Clinical Commentaries focus on clinical topics that are novel or controversial and require rapid dissemination. These articles may also highlight treatment options, protocols, and/or novel case treatments.
Mechanics: Commentaries should contain the following sections: Title Page, Introduction, Discussion, and Conclusion. We recommend Commentaries contain 1000-2000 words, 1-2 figures and/or tables, and 15-30 references.
Letters to the Editor: Letters to the Editor should focus on articles published within the journal during the last 12 months. These letters should be timely and seek to engage the authors of the original article in discussion. The authors of the original article will be asked to respond to a Letter to the Editor, commenting on their article. The Letter to the Editor and the Reply to the Letter to the Editor will be published together.
Mechanics: We recommend that letters contain 500-1000 words, and they may contain 1-2 figures and/or tables and 5-15 references.
Other Items: The journal also publishes highlights/reports of scientific meetings and book reviews. Please contact the editorial office for further information.
Contact details for submission
If you have questions regarding any of the requirements for submitting a manuscript to the Journal, please contact the editorial office at clbc@elsevier.com.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
……
更多详情：
https://www.elsevier.com/journals/clinical-breast-cancer/1526-8209/guide-for-authors
